Franklin Resources’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$196M Buy
601,331
+143,017
+31% +$46.6M 0.05% 316
2025
Q1
$124M Buy
458,314
+44,175
+11% +$11.9M 0.04% 390
2024
Q4
$97.5M Buy
414,139
+31,166
+8% +$7.33M 0.03% 431
2024
Q3
$109M Buy
382,973
+93,647
+32% +$26.5M 0.03% 411
2024
Q2
$70.3M Buy
289,326
+51,802
+22% +$12.6M 0.02% 464
2024
Q1
$35.5M Buy
237,524
+86,596
+57% +$12.9M 0.01% 687
2023
Q4
$28.9M Buy
150,928
+634
+0.4% +$121K 0.01% 661
2023
Q3
$26.6M Sell
150,294
-76
-0.1% -$13.5K 0.01% 663
2023
Q2
$28.6M Sell
150,370
-10,425
-6% -$1.98M 0.01% 684
2023
Q1
$32.2M Sell
160,795
-50
-0% -$10K 0.02% 646
2022
Q4
$38.2M Buy
160,845
+1,550
+1% +$368K 0.02% 599
2022
Q3
$31.9M Buy
159,295
+3,185
+2% +$638K 0.02% 649
2022
Q2
$22.8M Sell
156,110
-35,559
-19% -$5.19M 0.01% 760
2022
Q1
$31.3M Sell
191,669
-18,638
-9% -$3.04M 0.01% 740
2021
Q4
$35.7M Buy
210,307
+60,652
+41% +$10.3M 0.01% 735
2021
Q3
$28.3M Buy
149,655
+146,050
+4,051% +$27.6M 0.01% 808
2021
Q2
$611K Buy
3,605
+515
+17% +$87.3K ﹤0.01% 1568
2021
Q1
$436K Sell
3,090
-490
-14% -$69.1K ﹤0.01% 1627
2020
Q4
$466K Sell
3,580
-121,685
-97% -$15.8M ﹤0.01% 1562
2020
Q3
$18.2M Buy
125,265
+1,241
+1% +$181K 0.01% 785
2020
Q2
$19.6M Sell
124,024
-414
-0.3% -$65.4K 0.01% 738
2020
Q1
$13.5M Sell
124,438
-2,098
-2% -$228K 0.01% 751
2019
Q4
$14.6M Sell
126,536
-72,646
-36% -$8.37M 0.01% 826
2019
Q3
$16M Sell
199,182
-35
-0% -$2.82K 0.01% 787
2019
Q2
$14.5M Sell
199,217
-126
-0.1% -$9.14K 0.01% 819
2019
Q1
$18.6M Buy
+199,343
New +$18.6M 0.01% 764
2018
Q3
Sell
-78,900
Closed -$7.77M 1513
2018
Q2
$7.77M Sell
78,900
-46,500
-37% -$4.58M ﹤0.01% 964
2018
Q1
$14.9M Buy
125,400
+75,000
+149% +$8.93M 0.01% 847
2017
Q4
$6.4M Buy
50,400
+30,680
+156% +$3.9M ﹤0.01% 1028
2017
Q3
$2.32M Buy
+19,720
New +$2.32M ﹤0.01% 1205
2017
Q2
Sell
-508,317
Closed -$26.1M 1499
2017
Q1
$26.1M Sell
508,317
-12,100
-2% -$620K 0.01% 719
2016
Q4
$19.5M Sell
520,417
-193,583
-27% -$7.25M 0.01% 798
2016
Q3
$48.4M Buy
714,000
+122,000
+21% +$8.27M 0.03% 540
2016
Q2
$32.9M Sell
592,000
-351,723
-37% -$19.5M 0.02% 658
2016
Q1
$59.2M Sell
943,723
-24,102
-2% -$1.51M 0.03% 491
2015
Q4
$91.1M Buy
967,825
+29,200
+3% +$2.75M 0.05% 383
2015
Q3
$75.4M Sell
938,625
-71,372
-7% -$5.74M 0.04% 425
2015
Q2
$121M Sell
1,009,997
-116,048
-10% -$13.9M 0.06% 342
2015
Q1
$118M Sell
1,126,045
-1,012,441
-47% -$106M 0.05% 350
2014
Q4
$207M Sell
2,138,486
-123,391
-5% -$12M 0.09% 225
2014
Q3
$177M Sell
2,261,877
-277,324
-11% -$21.7M 0.08% 249
2014
Q2
$160M Sell
2,539,201
-60,195
-2% -$3.8M 0.07% 277
2014
Q1
$175M Buy
2,599,396
+455,286
+21% +$30.6M 0.08% 256
2013
Q4
$138M Buy
2,144,110
+100,470
+5% +$6.46M 0.07% 300
2013
Q3
$131M Buy
2,043,640
+1,759,640
+620% +$113M 0.07% 285
2013
Q2
$8.81M Buy
+284,000
New +$8.81M 0.01% 971